BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8103744)

  • 1. Physical association of the cytoplasmic domain of CD2 with the tyrosine kinases p56lck and p59fyn.
    Carmo AM; Mason DW; Beyers AD
    Eur J Immunol; 1993 Sep; 23(9):2196-201. PubMed ID: 8103744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both T cell receptor (TcR)-CD3 complex and CD2 increase the tyrosine kinase activity of p56lck. CD2 can mediate TcR-CD3-independent and CD45-dependent activation of p56lck.
    Danielian S; Alcover A; Polissard L; Stefanescu M; Acuto O; Fischer S; Fagard R
    Eur J Immunol; 1992 Nov; 22(11):2915-21. PubMed ID: 1358625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a signaling complex involving CD2, zeta chain and p59fyn in T lymphocytes.
    Gassmann M; Amrein KE; Flint NA; Schraven B; Burn P
    Eur J Immunol; 1994 Jan; 24(1):139-44. PubMed ID: 7912674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein tyrosine kinase p59fyn is associated with the T cell receptor-CD3 complex in functional human lymphocytes.
    Gassmann M; Guttinger M; Amrein KE; Burn P
    Eur J Immunol; 1992 Jan; 22(1):283-6. PubMed ID: 1530920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4-dependent and -independent association of protein tyrosine kinases to the T cell receptor/CD3 complex of CD4+ mouse T lymphocytes.
    Criado G; Feito MJ; Rojo JM
    Eur J Immunol; 1996 Jun; 26(6):1228-34. PubMed ID: 8647197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between the tyrosine kinases p56lck, p59fyn and p50csk in CD4 signaling in T cells.
    Baldari CT; Di Somma MM; Milia E; Bergman M; Telford JL
    Eur J Immunol; 1995 Apr; 25(4):919-25. PubMed ID: 7737294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn.
    Burgess KE; Yamamoto M; Prasad KV; Rudd CE
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9311-5. PubMed ID: 1384049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of CD2 association with T cell receptor signaling molecules in "CD2 unresponsive" human T lymphocytes.
    Schraven B; Wild M; Kirchgessner H; Siebert B; Wallich R; Henning S; Samstag Y; Meuer SC
    Eur J Immunol; 1993 Jan; 23(1):119-23. PubMed ID: 8093441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p56lck SH2 domain mediates recruitment of CD8/p56lck to the activated T cell receptor/CD3/zeta complex.
    Thome M; Germain V; DiSanto JP; Acuto O
    Eur J Immunol; 1996 Sep; 26(9):2093-2100. PubMed ID: 8814252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical identification of a direct physical interaction between the CD4:p56lck and Ti(TcR)/CD3 complexes.
    Burgess KE; Odysseos AD; Zalvan C; Druker BJ; Anderson P; Schlossman SF; Rudd CE
    Eur J Immunol; 1991 Jul; 21(7):1663-8. PubMed ID: 1829412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lymphocyte-specific tyrosine protein kinase p56lck is endocytosed in Jurkat cells stimulated via CD2.
    Marie-Cardine A; Maridonneau-Parini I; Ferrer M; Danielian S; Rothhut B; Fagard R; Dautry-Varsat A; Fischer S
    J Immunol; 1992 Jun; 148(12):3879-84. PubMed ID: 1351089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lymphocyte-specific tyrosine protein kinase p56lck.
    Veillette A; Abraham N; Caron L; Davidson D
    Semin Immunol; 1991 May; 3(3):143-52. PubMed ID: 1909593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tyrosine kinase activity of p56lck is increased in human T cells activated via CD2.
    Danielian S; Fagard R; Alcover A; Acuto O; Fischer S
    Eur J Immunol; 1991 Aug; 21(8):1967-70. PubMed ID: 1678351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p56lck association with CD4 is required for the interaction between CD4 and the TCR/CD3 complex and for optimal antigen stimulation.
    Collins TL; Uniyal S; Shin J; Strominger JL; Mittler RS; Burakoff SJ
    J Immunol; 1992 Apr; 148(7):2159-62. PubMed ID: 1532002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of p56lck and p59fyn protein expression in thymocyte subsets, peripheral T cells, NK cells, and lymphoid cell lines.
    Olszowy MW; Leuchtmann PL; Veillette A; Shaw AS
    J Immunol; 1995 Nov; 155(9):4236-40. PubMed ID: 7594580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective association between MHC class I-restricted T cell receptors, CDS, and activated tyrosine kinases on thymocytes undergoing positive selection.
    Carrera AC; Wee SB; Roberts TM; Pardoll DM
    J Immunol; 1992 Nov; 149(10):3142-9. PubMed ID: 1431093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of CD4 and CD8 in T cell activation.
    Miceli MC; Parnes JR
    Semin Immunol; 1991 May; 3(3):133-41. PubMed ID: 1909592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of hyporesponsiveness in lpr CD4-CD8- T cells is achieved by induction of cell cycling and normalization of CD2 and p59fyn expression.
    Clements JL; Wolfe J; Cooper SM; Budd RC
    Eur J Immunol; 1994 Mar; 24(3):558-65. PubMed ID: 7510235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5.
    Beyers AD; Spruyt LL; Williams AF
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2945-9. PubMed ID: 1372996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of tyrosine kinase p56lck with CD4 inhibits the induction of growth through the alpha beta T-cell receptor.
    Haughn L; Gratton S; Caron L; Sékaly RP; Veillette A; Julius M
    Nature; 1992 Jul; 358(6384):328-31. PubMed ID: 1322497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.